Ectris

Ectris is a drug produced by Boehringer Ingelheim. It is currently being investigated as a drug for women with decreased sexual desire. It is a 5-HT1A receptor full agonist, 5-HT2A receptor antagonist, and D4 receptor very weak partial agonist that had initially been developed as an antidepressant. As with Viagra, the effects of Ectris were discovered serendipitously after it was trialled as an antidepressant. Although touted as "Female Viagra" Ectris does not work like any PDE5 inhibitors. Ectris does not play a part in transferring increased amounts of blood to the female genital region as PDE5 inhibitors do to the male genital region. Female HSDD (Hypoactive Sexual Desire Disorder) is not similar to its male counterpart Erectile Dysfunction in the way it is treated. Some have argued that Female Sexual Dysfunction is merely Disease Mongering and a ploy to expand a market for sex drugs for women and to medicalize women's sexuality.